Investment Considerations Lexaria Bioscience Corp. has disruptive proprietary technology protected by a broad international patent portfolio. The company has been issued 37 patents in the U.S., European Union and other countries, with many more pending around the world. Lexaria’s DehydraTECH technology has a vast worldwide, multi-billion-dollar total addressable market, including multiple rapid-growth segments like cannabinoid … Continue reading “Lexaria Bioscience Corp. (NASDAQ: LEXX)”
Symbol | Release | Time |
---|---|---|
{{ release.qmtopics.qmsymbol[0].symbol }} | {{ release.headline }} | {{ release.datetime | amDateFormat:'hh:mm A'}} |